Evidence map›Paper›PMID 20722077›Full record

ArticleEuropean journal of immunology2010

Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells.

Ian R Humphreys, Seung-Woo Lee, Morgan Jones, Andrea Loewendorf, Emma Gostick, David A Price, Chris A Benedict, Carl F Ware, Michael Croft

Open access · bronzeAbstract read
In one paragraph

Article in European journal of immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 60 citations in OpenAlex.

  1. 4-1BB immunotherapy: advances and hurdles.Experimental & molecular medicine · 2024
    Review
  2. Article
  3. Review
  4. Optimal CD8Immunology · 2021
    Article
  5. Review
  6. Review
  7. Review
  8. Fuel and brake of memory T cell inflation.Medical microbiology and immunology · 2019
    Review
  9. Caspase-8 restricts antiviral CD8 T cell hyperaccumulation.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Cytomegalovirus: Shape-Shifting the Immune System.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Review
  16. The (gradual) rise of memory inflation.Immunological reviews · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. T cell responses to cytomegalovirus.Nature reviews. Immunology · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ian R HumphreysDivision of Molecular Immunology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, USA. humphreysir@Cardiff.ac.uk
Seung-Woo Lee
Morgan Jones
Andrea Loewendorf
Emma Gostick
David A Price
Chris A Benedict
Carl F Ware
Michael Croft
La Jolla Institute for Immunology · USCardiff University · GB

Funding

Treg stability in viral infection and autoimmunityP01AI089624 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI PETERS, BJOERN · 2010 to 2014
$10.1M
Anti-herpesvirus Signaling by LTalphabeta/LIGHT CytokinesR01AI048073 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WARE, CARL F · 2001 to 2016
$7.0M
Lymphotoxin alpha Beta and LIGHT cytokine systemsR37AI033068 · NIAID · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI WARE, CARL F · 2003 to 2012
$4.2M
The Role of 4-IBB in T Cell and APC InteractionsR01AI042944 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 1998 to 2010
$2.9M
Modulating Lymphotoxins for Viral DefensesR01AI057840 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI WARE, CARL F · 2005 to 2009
$2.4M
TNFR Members in T Cell Immunity to VacciniaR01AI067341 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2006 to 2010
$2.3M
SURFACE LYMPHOTOXIN A/B COMPLEXESR01AI033068 · NIAID · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI WARE, CARL F · 1994 to 2002
$1.0M
TNFR Members in T Cell Immunity to VacciniaR56AI067341 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI CROFT, MICHAEL · 2012 to 2012
$348k
NIAID NIH HHS AI042944NIAID NIH HHS AI048073NIAID NIH HHS AI057840NIAID NIH HHS AI33068NIAID NIH HHS AI67341NIAID NIH HHS P01 AI089624NIAID NIH HHS R01 AI033068NIAID NIH HHS R01 AI042944NIAID NIH HHS R01 AI048073NIAID NIH HHS R01 AI057840NIAID NIH HHS R01 AI067341NIAID NIH HHS R37 AI033068NIAID NIH HHS R56 AI067341Wellcome TrustWellcome Trust WT082249
6 · The paper itself

Abstract

The initial requirement for the emergence of CMV-specific CD8(+) T cells is poorly understood. Mice deficient in the cosignaling TNF superfamily member, 4-1BB, surprisingly developed exaggerated early CD8(+) T-cell responses to mouse CMV (MCMV). CD8(+) T cells directed against acute MCMV epitopes were enhanced, demonstrating that 4-1BB naturally antagonizes these primary populations. Paradoxically, 4-1BB-deficient mice displayed reduced accumulation of memory CD8(+) T cells that expand during chronic/latent infection. Importantly, the canonical TNF-related ligand, 4-1BBL, promoted the accumulation of these memory CD8(+) T cells, whereas suppression of acute CD8(+) T cells was independent of 4-1BBL. These data highlight the dual nature of the 4-1BB/4-1BBL system in mediating both stimulatory and inhibitory cosignaling activities during the generation of anti-MCMV immunity.

Indexed as

4-1BB LigandAnimalsCD8-Positive T-LymphocytesDNA, ViralHerpesviridae InfectionsImmunologic MemoryInterferon-gammaLungMiceMice, Inbred C57BLMice, KnockoutMuromegalovirusPolymerase Chain ReactionSpleenTumor Necrosis Factor Receptor Superfamily, Member 9Viral Envelope Proteins4-1BB LigandDNA, Viralglycoprotein B, SimplexvirusInterferon-gammaTumor Necrosis Factor Receptor Superfamily, Member 9Viral Envelope Proteins

Identifiers

PMID20722077
PMCPMC2967573
OpenAlexW2153627364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.